A new GlobalData study shows that Type 2 diabetes is carrying a growing burden of comorbidities across the seven major markets, United Kingdom, United States, Japan, France, Germany, Italy, and Spain.
Its latest report, “Type 2 Diabetes (T2D): Epidemiology Forecast to 2035,” projects that the burden of diagnosed prevalent cases of type 2 diabetes in these markets is expected to increase at an annual growth rate of 1.2% from 54.5 million in 2025 to 61.2 million cases in 2035.
The intelligence and productivity platform found that hypertension was the most prevalent diagnosed condition among patients with the Type 2 diabetes, and called for more comprehensive disease management and prevention strategies.
Higher BMI, sedentary lifestyles, poor diets, and aging populations are intensifying this burden.
BMI tends to be higher in developed countries, especially in Western Europe and the US due to diets high in processed foods, sedentary lifestyles, and the prevalence of desk jobs.
Additionally, aging populations play a large role in the increasing prevalence of type 2 diabetes.
GlobalData epidemiologists observed that though comorbidity prevalence varied across the markets, hypertension made up most diagnosed prevalent cases with a diagnosed comorbidity.
The highest proportion of comorbid hypertension was observed in Germany.
Meanwhile, in England there has been an increase in young women in their 20s developing type 2 diabetes, according to an Imperial College London study.
The study found that while incidence declined among older adults, who still account for most new cases, but increased sharply in people younger than 40.
The analysis shows that the rise is particularly noticeable in White, Asian and Black women aged 20–29 years, and in White women aged 30–39 years.
